# BRIEFING — 2026-11-11T04:41:00Z

## Mission
Verify resolution of 4 round-1 review findings for Milestone 3 (Combat 29->6 rebalancing, impact card, Tab 3 backtest comparison, dynamic rebalance toggle) and adversarial stress-test.

## 🔒 My Identity
- Archetype: reviewer_and_adversarial_critic
- Roles: reviewer, critic
- Working directory: d:\Google\Workspace\Wind
- State folder: d:\Google\Workspace\Wind\.agents\teamwork\reviewer_g16_m3_r2_1\
- Original parent: 8e0dcc03-29f3-4005-b23c-b17f3ff94035
- Milestone: Milestone 3 Round 2 Review
- Instance: 1 of 1

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code
- Check for integrity violations (hardcoding, facade implementations, test bypasses)
- Follow Chinese language response rule for all messages

## Current Parent
- Conversation ID: 8e0dcc03-29f3-4005-b23c-b17f3ff94035
- Updated: 2026-11-11T04:32:53Z

## Review Scope
- **Files to review**: `strategy_bridge.py`, `app_gui.py`, `tests/test_m3_item2_rebalance_impact.py`, `tests/test_m3_item3_tab3_backtest.py`, `tests/test_adversarial_m3_combat29_challenger.py`
- **Interface contracts**: `d:\Google\Workspace\Wind\.agents\teamwork\orchestrator_g16_gen4\SCOPE.md`, `d:\Google\Workspace\Wind\.agents\teamwork\reviewer_g16_m3_1\handoff.md`, `d:\Google\Workspace\Wind\.agents\teamwork\worker_g16_m3_fix\handoff.md`
- **Review criteria**: Correctness of round-1 bug fixes, integrity (no fake constants/facades), test coverage and pass rate, adversarial robustness.

## Key Decisions Made
- Confirmed all 4 Round 1 findings genuinely resolved in source code.
- Verified test suite passes: 22/22 tests in target test suite, 14/14 referee baseline tests, 18/18 adversarial stress tests, 14/14 full regression suite.
- Verdict decided: APPROVE.

## Artifact Index
- `DISPATCH.md` — assignment and dispatch message
- `BRIEFING.md` — persistent working memory
- `progress.md` — liveness heartbeat
- `handoff.md` — final handoff review report

## Review Checklist
- **Items reviewed**: `strategy_bridge.py`, `app_gui.py`, `tests/test_m3_item2_rebalance_impact.py`, `tests/test_m3_item3_tab3_backtest.py`, `tests/test_adversarial_m3_combat29_challenger.py`, `scripts/verify_m3_r2_empirical.py`, `scripts/test_m3_r2_adversarial_deep_stress.py`
- **Verdict**: APPROVE
- **Unverified claims**: None. All 4 claims independently verified via code inspection and runtime execution.

## Attack Surface
- **Hypotheses tested**:
  - Step 3 prescription funds dictionary schema conformance: verified all 6 funds have valid code/name/weight_pct
  - Tab 2 dynamic metrics calculation under extreme portfolio scales: verified duck-typing, micro/mega scales, 0 fees, payback days
  - Tab 3 curve naming under preset vs diff_rebal vs pk_ledgers: verified no curve inversion
  - Time Machine dynamic rebalance toggle at 2024-09-18: verified dynamic +32.29% vs static +6.73%, alpha +7.77%
- **Vulnerabilities found**: None remaining in Round 2.
- **Untested angles**: None.
